About the Series

The Entrepreneurial Management Center is proud to announce the 13th year of the L. Robert Payne Distinguished Entrepreneur Lecture Series. The lecture series brings an outstanding entrepreneur to San Diego State University to speak to and interact with students, faculty, and invited business representatives from the regional entrepreneurial community.

This year we are pleased to announce that Dr. Tina Nova, Co-Founder, President, CEO and Director of Genoptix, Inc.. She will share stories of her challenges and successes and offer words of wisdom. Please join us on Tuesday, November 17, 2009 in the Aztec Athletic Center Auditorium from 4:00-7:00pm to hear about Dr. Nova's exciting entrepreneurial journey.

The lecture series was established in 1996 with a gift from SDSU alumnus Bob Payne, a successful entrepreneur and long-time supporter of the Entrepreneurial Management Center. Past lecturers include:

• Norm Brinker, former Chairman of Brinker International
• Jim Sinegal, President & CEO of Costco
• John Moores, Founder of Peregrine Systems & Chairman of the Padres
• John Sarkisian, Co-Founder, Pat & Oscar's Restaurants
• Dr. Irwin Jacobs, Chairman & CEO of QUALCOMM
• Robert J. Nugent, former Chairman & CEO of Jack in the Box
• Russell Lewis, Founder and CEO of Rhino Linings
• Dr. Robert Beyster, Founder of SAIC
• Ron Fowler, Chairman & CEO of Liquid Investments, Inc.

The event consists of a lecture from 4:00 - 5:30pm, followed by a reception from 5:30 - 7:00pm. Additionally, based upon their availability, previous speakers have participated in a luncheon with EMC directors and other distinguished guests, and/or an informal roundtable session with a small group of select entrepreneurship students.

About Tina Nova:

Tina S. Nova, Ph.D. has served as Genoptix President, CEO and a member of our Board of Directors, since March 2000. From 1994 to January 2000, Dr. Nova served as chief operating officer and president of Nanogen, Inc., a provider of molecular diagnostic tests, where she was a co-founder. From 1992 to 1994, Dr. Nova served as chief operating officer of Selective Genetics, a targeted therapy biotechnology company. Dr. Nova holds a B.S. degree in biological sciences from the University of California, Irvine and a Ph.D. in biochemistry from the University of California, Riverside.

About Genoptix:

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix' highly trained hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Co-founded by Dr. Nova in 2000, Genoptix completed its initial public offering in November 2007 and has been profitable since the first quarter of that year. Genoptix is a member the S&P SmallCap 600 Index and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Contact

For more information, please contact:
Bernhard Schroeder, Director, EMC Programs at bschroeder@projects.sdsu.edu.